Clinical Trial Update: Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing hydralazine to labetalol for managing hypertensive disorders of pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Disorders of Pregnancy
• Pregnancy-induced Hypertension

Drugs mentioned

• Hydralazine (hydralazine)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Saint Thomas Hospital, Panama | Conditions: Hypertension, Pregnancy Induced | Phase 3 | Status: COMPLETED